UniQuest is commercialising a range of new oncology therapeutics, including vaccines, drugs and other therapies to treat cancers relating to skin, hormone-dependendence, ovarian, breast, cervical, prostate, brain, bone and blood. UniQuest is also involved with new approaches to combat the side effects of cancer treatments, such as chemotherapy and radiotherapy.

Here's a sample of our oncology-related projects looking for commercial partners. If you would like more information on a project, let us know you're interested using the Quick Query form.

1. Breast cancer brain metastases treatment
2. Breast cancer combination therapy
3. Breast cancer CRAC modulator
4. Fluorodex
5. Vac-K4 - hormone dependent cancers
6. TheraPhil - neutropenia therapy
7. Chronic Lymphocitic Leukaemia therapy
8. Multiple myeloma treatment
9. C-Sign - signalling pathway
10. Coridon - skin cancer

Sign up to receive all the latest news about UniQuest's investment and licensing portfolio with The Deal Sheet, or visit our News pages.

Back to Research Innovation Portfolio

cancer, oncology, breast, hormone-dependent, prostate, metastases, chemotherapy, leukaemia, myeloma, neutropenia, theraphils